Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 541-550 of 1154 total displayed.

Past content (since Jan 1999):

Articles
Amiodarone Therapy for Drug-Refractory Fetal Tachycardia
Janette F. Strasburger, Bettina F. Cuneo, Maaike M. Michon, Nina L. Gotteiner, Barbara J. Deal, Scott N. McGregor, Martijn A. Oudijk, Erik J. Meijboom, Leonard Feinkind, Michael Hussey, and Barbara V. Parilla
Circulation published January 19, 2004, doi:10.1161/01.CIR.0000109494.05317.58 [Abstract]  

Review: Current Perspective
Can Angiotensin II Type 2 Receptors Have Deleterious Effects in Cardiovascular Disease?: Implications for Therapeutic Blockade of the Renin–Angiotensin System
Bernard I. Lévy
Circulation 2004;109:8-13, doi:10.1161/01.CIR.0000096609.73772.C5 [Full text]  

Articles
Effects of Carvedilol on Left Ventricular Remodeling After Acute Myocardial Infarction. The CAPRICORN Echo Substudy
Robert N. Doughty, Gillian A. Whalley, Helen A. Walsh, Greg D. Gamble, José López-Sendón, Norman Sharpe on behalf of the CAPRICORN Echo Substudy Investigators
Circulation published January 5, 2004, doi:10.1161/01.CIR.0000108928.25690.94 [Abstract]  

Correspondence
Fibrinolytic Therapy: What Size to Fit All? Response
Mario Ivanusa, Paul W. Armstrong, Désiré Collen, and Elliott Antman
Circulation 2003;108:e170, doi:10.1161/01.CIR.0000108167.21070.15 [Full text]  

Correspondence
Aldosterone Blockade in Patients With Acute Myocardial Infarction Response
Henry A. Solomon and Bertram Pitt
Circulation 2003;108:e173, doi:10.1161/01.CIR.0000108171.05172.D4 [Full text]  

Clinician Update
Cardiovascular Pharmacogenomics
Dan M. Roden
Circulation 2003;108:3071-3074, doi:10.1161/01.CIR.0000110626.24310.18 [Full text]  

Basic Science Reports
Pharmacological Modulation of Cardiac Gap Junctions to Enhance Cardiac Conduction: Evidence Supporting a Novel Target for Antiarrhythmic Therapy
Benjamin C. Eloff, Eran Gilat, Xiaoping Wan, and David S. Rosenbaum
Circulation 2003;108:3157-3163; published online before print as doi:10.1161/01.CIR.0000101926.43759.10 [Abstract] [Full text]  

Brief Rapid Communications
Methoxyestradiols Mediate the Antimitogenic Effects of 17ß-Estradiol: Direct Evidence From Catechol-O-Methyltransferase–Knockout Mice
Lefteris C. Zacharia, Joseph A. Gogos, Maria Karayiorgou, Edwin K. Jackson, Delbert G. Gillespie, Federica Barchiesi, and Raghvendra K. Dubey
Circulation 2003;108:2974-2978; published online before print as doi:10.1161/01.CIR.0000106900.66354.30 [Abstract] [Full text]  

Correspondence
Bosentan and Overcirculation-Induced Experimental Pulmonary Arterial Hypertension Response
Michael V. Ullmann, Matthias Gorenflo, Benoit Rondelet, François Kerbaul, Sophie Motte, Serge Brimioulle, Kathleen McEntee, Pierre Wauthy, Robert Naeije, Ronald van Beneden, Jean-Marie Keteslegers, Myriam Remmelink, and Isabelle Salmon
Circulation 2003;108:e157, doi:10.1161/01.CIR.0000102941.83506.6E [Full text]  

Articles
Methoxyestradiols Mediate the Antimitogenic Effects of 17{beta}-Estradiol. Direct Evidence From Catechol-O-Methyltransferase-Knockout Mice
Lefteris C. Zacharia, Joseph A. Gogos, Maria Karayiorgou, Edwin K. Jackson, Delbert G. Gillespie, Federica Barchiesi, and Raghvendra K. Dubey
Circulation published December 8, 2003, doi:10.1161/01.CIR.0000106900.66354.30 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment